Shell disease, commonly known as shell rot, represents one of the most significant health challenges affecting marine crustaceans in both wild and captive populations. This condition involves the progressive degradation of the chitinous exoskeleton through bacterial action, resulting in characteristic erosive lesions, discoloration, and structural weakening of the protective outer covering. The exoskeleton serves as the crustacean's primary defense against environmental hazards, pathogens, and physical injury, making any compromise of this structure a serious threat to survival. Shell disease has been documented across virtually all marine crustacean groups, from microscopic copepods to large commercially valuable species like lobsters and crabs, establishing it as a ubiquitous concern for anyone keeping or studying these invertebrates.
Marine crustaceans affected by shell disease span the full diversity of species commonly encountered in aquarium keeping and marine research facilities. True crabs including various Brachyuran species popular in reef aquariums frequently develop shell rot when environmental conditions deteriorate. Hermit crabs of both marine and semi-terrestrial types experience shell disease affecting both their own exoskeleton and potentially the gastropod shells they inhabit. Lobsters, particularly American and spiny lobster species kept in research or aquaculture settings, have well-documented shell disease syndromes. Marine shrimp ranging from tiny ornamental species to large penaeid shrimp encounter this condition. Porcelain crabs, squat lobsters, and other anomuran crustaceans share susceptibility. The widespread occurrence across taxonomic groups indicates that the underlying mechanisms relate to fundamental aspects of crustacean biology rather than species-specific vulnerabilities.
The impact of shell disease on crustacean health extends far beyond cosmetic damage to the exoskeleton. As lesions deepen and expand, they may breach the exoskeleton entirely, exposing underlying soft tissues to environmental pathogens and creating portals of entry for systemic infections. The chitinase enzymes produced by causative bacteria continue degrading the shell matrix, weakening structural integrity and increasing vulnerability to physical damage. Shell disease lesions may penetrate to the epidermis, damaging the cellular layer responsible for producing new exoskeleton material during molting. Affected crustaceans experience increased metabolic demands as their immune systems attempt to contain infections, diverting resources from growth, reproduction, and other normal functions. Secondary complications including systemic bacterial septicemia frequently develop in advanced cases, contributing to the high mortality associated with severe shell disease.
The treatability and prognosis for shell disease vary considerably depending on when the condition is identified and how aggressively environmental issues are addressed. Early-stage lesions limited to superficial exoskeleton layers often resolve completely at the next molt, when the affected shell is shed and replaced with new, healthy integument. However, deep lesions that have damaged the underlying epidermis may not resolve with molting and can even persist or worsen through multiple molt cycles. Cases where systemic bacterial infection has developed carry poor prognoses regardless of local wound management. Prevention through optimal husbandry practices remains far more effective than attempting to treat established infections. The fundamental principle underlying both prevention and treatment is that shell disease typically develops when environmental stressors compromise the crustacean's natural resistance mechanisms, making water quality management the cornerstone of any control strategy.
